Literature DB >> 12521571

Gastroesophageal Reflux Disease.

Amine Hila1, Donald O. Castell.   

Abstract

Lifestyle modifications should be discussed with every patient with symptoms of chronic gastroesophageal reflux disease (GERD). Proton pump inhibitors are the most efficacious medical therapy for GERD. H(2) receptor antagonists are likely to be effective in patients with mild to moderate GERD and for occasional symptoms. Promotility drugs have limited efficacy and produce frequent side effects. Surgery is a reasonable option for chronic management. Endoscopic therapy remains experimental until more long-term results are available.

Entities:  

Year:  2003        PMID： 12521571     DOI： 10.1007/s11938-003-0032-7

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN： 1092-8472


  21 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

2.  Transoral, flexible endoscopic suturing for treatment of GERD: a multicenter trial.

Authors:  C J Filipi; G A Lehman; R I Rothstein; I Raijman; G V Stiegmann; J P Waring; J G Hunter; C J Gostout; S A Edmundowicz; D P Dunne; P A Watson; D A Cornet
Journal:  Gastrointest Endosc       Date:  2001-04       Impact factor: 9.427

3.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

4.  Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

Authors:  E C Klinkenberg-Knol; F Nelis; J Dent; P Snel; B Mitchell; P Prichard; D Lloyd; N Havu; M H Frame; J Romàn; A Walan
Journal:  Gastroenterology       Date:  2000-04       Impact factor: 22.682

5.  Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.

Authors:  L Lundell; P Miettinen; H E Myrvold; S A Pedersen; B Liedman; J G Hatlebakk; R Julkonen; K Levander; J Carlsson; M Lamm; I Wiklund
Journal:  J Am Coll Surg       Date:  2001-02       Impact factor: 6.113

6.  Healing and relapse of severe peptic esophagitis after treatment with omeprazole.

Authors:  D J Hetzel; J Dent; W D Reed; F M Narielvala; M Mackinnon; J H McCarthy; B Mitchell; B R Beveridge; B H Laurence; G G Gibson
Journal:  Gastroenterology       Date:  1988-10       Impact factor: 22.682

7.  The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial.

Authors:  George Triadafilopoulos; John K DiBaise; Timothy T Nostrant; Neil H Stollman; Paul K Anderson; M Michael Wolfe; Richard I Rothstein; John M Wo; Douglas A Corley; Marco G Patti; Louis V Antignano; John S Goff; Steven A Edmundowicz; Donald O Castell; John C Rabine; Michael S Kim; David S Utley
Journal:  Gastrointest Endosc       Date:  2002-02       Impact factor: 9.427

8.  Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors.

Authors:  P L Peghini; P O Katz; N A Bracy; D O Castell
Journal:  Am J Gastroenterol       Date:  1998-05       Impact factor: 10.864

9.  Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors.

Authors:  P O Katz; C Anderson; R Khoury; D O Castell
Journal:  Aliment Pharmacol Ther       Date:  1998-12       Impact factor: 8.171

10.  Meta-Analyses of Cisapride, Omeprazole and Ranitidine in the Treatment of GORD: Implications for Treating Patient Subgroups.

Authors:  M Iskedjian; T R Einarson
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.